Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06550674 | Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma(IGCMU) | recruiting | N/A | 50 | Centre Jean PerrinOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07364474 | Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver | recruiting | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07112170 | Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma(CURB-Melanoma) | recruiting | N/A | 52 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07225036 | Promoting Immunotherapy Efficacy With Low-Dose Liver RT(PRIME-LRT) | recruiting | N/A | 21 | Jordan KharofaOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07428252 | Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma | active not recruiting | N/A | 150 | Institute of Oncology LjubljanaOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07422779 | Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia(MAK) | recruiting | N/A | 100 | Institute of Oncology LjubljanaOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07404605 | Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma | recruiting | N/A | 150 | Institute of Oncology LjubljanaOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)(IT-TCP POS) | recruiting | N/A | 300 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407166 | Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers | recruiting | N/A | 40 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05121545 | Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors(ProGRID) | active not recruiting | N/A | 11 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07307534 | Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study | not yet recruiting | N/A | 60 | Xijing HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07161310 | Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors(MitoCancer) | recruiting | N/A | 45 | Goethe UniversityOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT01266096 | PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study | active not recruiting | N/A | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05307289 | Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma(MEL-META) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT02307630 | PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study | active not recruiting | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06508775 | Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies(LONGSAFE) | recruiting | N/A | 40 | Miltenyi Biomedicine GmbHINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06206707 | FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis(Immunobiome) | recruiting | N/A | 20 | University of AarhusOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT04513028 | Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma | recruiting | N/A | 30 | Kelly McMastersOTHER | 1 | Oct 30, 2025 | clinicaltrials |
| NCT07206017 | Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.(MELFIB) | recruiting | N/A | 20 | University Medical Center GroningenOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05839912 | Excision of Lymph Node Trial (EXCILYNT) (Mel69)(EXCILYNT) | recruiting | N/A | 66 | Craig L Slingluff, JrOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06880198 | Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma(MELA-IMPACT) | recruiting | N/A | 20 | Fondazione Melanoma OnlusOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04424719 | Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)(SALOME) | recruiting | N/A | 700 | Institut CurieOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07114172 | Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers | not yet recruiting | N/A | 15 | Xijing HospitalOTHER | 0 | Aug 11, 2025 | clinicaltrials |
| NCT06754904 | Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node(OMIT) | recruiting | N/A | 213 | D.J. (Dirk) GrünhagenOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07050940 | Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study | recruiting | N/A | 35 | Azienda Ospedaliera di PerugiaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07028008 | Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors | not yet recruiting | N/A | 9 | Samsung Medical CenterOTHER | 0 | Jun 26, 2025 | clinicaltrials |
| NCT06643286 | Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma(Melanoma SCP) | recruiting | N/A | 180 | Erasmus Medical CenterOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06970236 | Resistance Exercise in Patients With Ocular Melanoma(IHOPE) | recruiting | N/A | 40 | University of ValenciaOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05592639 | VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer(VELRAD) | active not recruiting | N/A | 50 | University College, LondonOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04385732 | Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients(IMAGE) | active not recruiting | N/A | 670 | Melanoma and Skin Cancer Trials LimitedOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04576429 | Immune Profiles Evolution Under Immunotherapy for Melanoma(EPITHEM) | recruiting | N/A | 360 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03888950 | Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy(TEP-ANTI-PD1) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06488365 | In Vivo Liquid Biopsy of Melanoma (Cytophone)(Cytophone) | recruiting | N/A | 180 | CytoastraINDUSTRY | 1 | Mar 11, 2025 | clinicaltrials |
| NCT04793737 | Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases(PROMMEL) | recruiting | N/A | 27 | Karolinska University HospitalOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06363591 | WoW - Single- vs Two-staged Excisions of Thin Melanoma(WoW) | recruiting | N/A | 2,486 | Vastra Gotaland RegionOTHER_GOV | 1 | Mar 5, 2025 | clinicaltrials |
| NCT05652673 | Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial | recruiting | N/A | 80 | Erasmus Medical CenterOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06767332 | EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial(FAME) | recruiting | N/A | 30 | Leiden University Medical CenterOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT03116412 | A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma(TRIM) | recruiting | N/A | 1,300 | Uppsala UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT02385214 | MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma(MelMarT) | active not recruiting | N/A | 400 | Melanoma and Skin Cancer Trials LimitedOTHER | 5 | Nov 27, 2024 | clinicaltrials |
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma(MelMarT-II) | recruiting | N/A | 2,998 | Melanoma and Skin Cancer Trials LimitedOTHER | 10 | Nov 27, 2024 | clinicaltrials |
| NCT06666790 | DermaSensor Postmarket Surveillance Study | recruiting | N/A | 396 | DermaSensor, Inc.INDUSTRY | 1 | Oct 31, 2024 | clinicaltrials |
| NCT05878977 | Biomarkers in Immunotherapy of Melanoma | recruiting | N/A | 150 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04605146 | Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy(MONITOR) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT05478876 | Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract(CYCLE) | recruiting | N/A | 9 | CNAO National Center of Oncological HadrontherapyOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06553781 | A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma | not yet recruiting | N/A | 28 | Fudan UniversityOTHER | 0 | Aug 14, 2024 | clinicaltrials |
| NCT05649683 | Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors(mela-quantif) | recruiting | N/A | 60 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05029791 | Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients(COLEMAN) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT05570227 | Metabolic Phenotypes in Melanoma(MetaMel) | recruiting | N/A | 240 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05253872 | The MELAcare Study: A New Method for Surveillance of Melanoma Patients | recruiting | N/A | 378 | Herlev and Gentofte HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Mar 19, 2026source: clinicaltrials